HANSA BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.93 USD | -9.98% |
|
-.--% | +29.82% |
| 04-18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 | |
| 04-18 | Hansa Biopharma AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Performance
| 1 day | -9.98% | ||
| 3 months | -9.98% | ||
| 6 months | -2.33% | ||
| Current year | +29.82% | ||
| 1 year | -44.66% | ||
| 3 years | -83.28% | ||
| 5 years | -84.87% |
Volumes
marketsDaily volume
150
Estimated daily volume
150
Record volume 1
28 000
Record volume 2
17 500
Record volume 3
12 500
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
249 175 837
Net sales (SEK)
134 094 000
Net sales (USD)
12 493 002
Number of employees
166
Sales / Employee (SEK)
807 795
Sales / Employee (USD)
75 259
Free-Float
88.64 %
Free-Float capitalization (USD)
191 696 377
Highs and lows
Current year
2.65
3.30
1 year
2.264.76
3 years
2.2618.20
5 years
2.2629.50
10 years
2.2635.91
Indicators
Moving average 5 days
2.93
Moving average 20 days
1.50
Moving average 50 days
0.60
Moving average 100 days
2.88
Price spread / (MMA5)
-.--%
Price spread / (MMA20)
-48.79%
Price spread / (MMA50)
-79.52%
Price spread / (MMA100)
-1.76%
RSI 9 days
54.95
RSI 14 days
55.09
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -9.98% | -.--% | +29.82% | -44.66% | 249M | ||
| +0.42% | +27.08% | +64.92% | +29.41% | 62.59B | ||
| +0.47% | -2.82% | -1.85% | +12.55% | 41.18B | ||
| +0.27% | -3.80% | +44.76% | -11.30% | 40.29B | ||
| -0.70% | -3.88% | -8.93% | +3.15% | 27.9B | ||
| +0.97% | -0.56% | +13.05% | +48.21% | 26.21B | ||
| -1.01% | +1.34% | -21.96% | -22.63% | 19.09B | ||
| -3.10% | -3.70% | +4.21% | -4.51% | 13.08B | ||
| +0.02% | +1.40% | +25.74% | +26.49% | 12.26B | ||
| +0.19% | -3.77% | +27.42% | +86.38% | 12.05B | ||
| -0.66% | -6.45% | -7.97% | +8.05% | 11.28B | ||
| -0.76% | -5.68% | -3.58% | -6.82% | 9.65B | ||
| -4.12% | -3.20% | +32.95% | +42.86% | 6.56B | ||
| -0.31% | -4.12% | +11.00% | +82.03% | 6.43B | ||
| -3.09% | -3.15% | +0.25% | -38.84% | 6.39B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | -1.34% | -0.28% | +13.99% | +14.02% | ||
| Weighted average by Cap. | -0.20% | +3.52% | +21.46% | +15.93% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +29.82% | ||
| 2023 | -54.22% | ||
| 2022 | -51.19% | ||
| 2021 | -65.76% | ||
| 2020 | +224.53% | ||
| 2019 | -71.32% | ||
| 2018 | +8.04% | ||
| 2017 | +112.76% | ||
| 2016 | +329.60% | ||
| 2015 | -30.22% |
- Stock Market
- Equities
- HNSA Stock
- HNSBF Stock
- Quotes Hansa Biopharma AB
